Pitch 2-4 : Takuji Yamamoto, Matrixome, Inc.

R-5 Matrixome.png profile photo_20180515.jpg

Mr. Yamamoto will pitch in Pitch Session 2!
山本氏はPitch Session 2に登壇予定!

Pitch Title

Cell culture substrate stands on 'MATRIXOME'


Takuji Yamamoto

CEO, Matrixome, Inc.

山本 卓司 氏

㈱マトリクソーム 代表取締役社長

Speaker Profile Mr. Yamamoto has had researched about prion disease and developed BSE/ TSE detection kit in Nippi Research Institute for BioMatrix. After developed that product, he has been researched and developed laminin-E8 fragment, and built Matrixome, Inc. with Prof. Sekiguchi for accelerating the research about matrixome. He became CEO at Jan. 2016.


HVC KYOTO 2018 will be held on July 3rd 2018!

Click here for the program.

To attend the event, please fill out the form from here!


HVC KYOTO 2018は2018/7/3に開催いたします。

当日のプログラムは こちら をご覧ください。

HVC KYOTO 2018への参加お申し込みは こちら から。